Pharma Leaders

Eli Lilly, Johnson & Johnson Invest in New Drug Manufacturing Facilities

3 months ago
by David Miller
946 Views

New facilities are expected to focus on manufacturing next-generation medicines and biologic medicines.

New facilities are expected to focus on manufacturing next-generation medicines and biologic medicines.

You may also like

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

Don`t Leave Yet!

Thank you!

[mwai_chat window="true" fullscreen="true"]